Alzheimer’s disease (AD): investigations
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Alzheimer’s disease (AD): investigations. Vitamin B12, Folate, Glucose, Calcium, Full blood count. Fully referenced neurology checklist.
Blood tests
- Vitamin B12
- Folate
- Glucose
- Calcium
- Full blood count
- Liver function tests
- Renal function tests
- Thyroid function tests
- Syphilis screening
- Lyme serology
- HIV screening
- Consider genetics
Magnetic resonance imaging (MRI): features
Locked: subscribe to see this section.
Amyloid positron emission tomography (amyloid PET)
Locked: subscribe to see this section.
TAU positron emission tomography (Tau PET)
Locked: subscribe to see this section.
Other imaging
Locked: subscribe to see this section.
Cerebrospinal fluid (CSF) analysis
Locked: subscribe to see this section.
Neurophysiology
Locked: subscribe to see this section.
References
- Hort J, O’Brien JT, Gianotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur J Neurol 2010; 17:1236-1248.
- Inoue Y, Nakajima M, Uetani H, et al. Diagnostic significance of cortical superficial siderosis for Alzheimer disease in patients with cognitive impairment. Am J Neuroradiol 2016; 37:223-227.
- Lorenzi RM, Palesi F, Castellazzi G, et al. Unsuspected involvement of spinal cord in alzheimer disease. Front Cell Neurosci 2020; 14:6.
- Bakkour A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009; 72:1048–1055.
- Weston PS, Nicholas JM, Lehmann M, et al. Presymptomatic cortical thinning in familial Alzheimer disease: a longitudinal MRI study. Neurology 2016; 87:2050-2057.
- And 6 more. Subscribe to see the full list
Related checklists
- Alzheimer’s disease (AD): risk factors
- Alzheimer’s disease (AD): protective factors
- Alzheimer’s disease (AD): clinical features
- Alzheimer's Disease (AD) v frontotemporal dementia (FTD)
- Alzheimer’s disease (AD): emerging investigations
- Alzheimer’s disease (AD): preventative measures
- Alzheimer’s disease (AD): non-drug management
- Alzheimer’s disease (AD): conventional drug treatments
- Alzheimer’s disease (AD): lecanemab treatment
- Alzheimer’s disease (AD): investigational treatments
- Alzheimer’s disease: driving and safety issues